VistaGen Therapeutics (NasdaqCM:VTGN) 2025 Conference November 12, 2025 03:20 PM ET Speaker2Very much. It's my pleasure to be moderating this chat with Shawn Singh, President and CEO of VistaGen Therapeutics. Certainly timing as we await some phase three data coming up in the next couple of months. Maybe, Shawn, you can just set the stage, give a quick background on the company, and then we'll do Q&A.Speaker3Great. Appreciate it. Thanks for having us.Speaker2Of course.Speaker3Always great to see you. I don' ...